Cover Image
市場調查報告書

High Point Pharmaceuticals, LLC:產品平台分析

High Point Pharmaceuticals, LLC - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 256012
出版日期 內容資訊 英文 28 Pages
訂單完成後即時交付
價格
Back to Top
High Point Pharmaceuticals, LLC:產品平台分析 High Point Pharmaceuticals, LLC - Product Pipeline Review - 2014
出版日期: 2014年12月10日 內容資訊: 英文 28 Pages
簡介

High Point Pharmaceuticals, LLC 是開發臨床階段製藥的企業,致力於開發可因應世間高度需求的治療藥。該公司更特別以中樞神經系統疾病,糖尿病,並且肥胖和血脂異常症,青光眼等相關併發症的治療藥開發為重點。

High Point Pharmaceuticals, LLC的基本資料

  • High Point Pharmaceuticals, LLC概要
  • 主要資訊
  • 企業資料

High Point Pharmaceuticals, LLC:R&D概要

  • 主要的治療範圍

High Point Pharmaceuticals, LLC:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

High Point Pharmaceuticals, LLC:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

High Point Pharmaceuticals, LLC:藥物簡介

  • HPP-404
  • HPP-851
  • HPP-593
  • HPP-854
  • HPP-737
  • HPP-971

High Point Pharmaceuticals, LLC:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

High Point Pharmaceuticals, LLC:最近的開發平台趨勢

High Point Pharmaceuticals, LLC:暫停中的計劃

High Point Pharmaceuticals, LLC:企業發表

High Point Pharmaceuticals, LLC:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06607CDB

Summary

Global Markets Direct's, 'High Point Pharmaceuticals, LLC - Product Pipeline Review - 2014', provides an overview of the High Point Pharmaceuticals, LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of High Point Pharmaceuticals, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of High Point Pharmaceuticals, LLC including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of High Point Pharmaceuticals, LLC's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the High Point Pharmaceuticals, LLC's pipeline products

Reasons to buy

  • Evaluate High Point Pharmaceuticals, LLC's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of High Point Pharmaceuticals, LLC in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the High Point Pharmaceuticals, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of High Point Pharmaceuticals, LLC and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of High Point Pharmaceuticals, LLC
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of High Point Pharmaceuticals, LLC and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • High Point Pharmaceuticals, LLC Snapshot
    • High Point Pharmaceuticals, LLC Overview
    • Key Information
    • Key Facts
  • High Point Pharmaceuticals, LLC - Research and Development Overview
    • Key Therapeutic Areas
  • High Point Pharmaceuticals, LLC - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • High Point Pharmaceuticals, LLC - Pipeline Products Glance
    • High Point Pharmaceuticals, LLC - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • High Point Pharmaceuticals, LLC - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • High Point Pharmaceuticals, LLC - Drug Profiles
    • HPP-404
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HPP-851
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HPP-593
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HPP-854
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HPP-737
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HPP-971
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • High Point Pharmaceuticals, LLC - Pipeline Analysis
    • High Point Pharmaceuticals, LLC - Pipeline Products by Target
    • High Point Pharmaceuticals, LLC - Pipeline Products by Route of Administration
    • High Point Pharmaceuticals, LLC - Pipeline Products by Molecule Type
    • High Point Pharmaceuticals, LLC - Pipeline Products by Mechanism of Action
  • High Point Pharmaceuticals, LLC - Recent Pipeline Updates
  • High Point Pharmaceuticals, LLC - Dormant Projects
  • High Point Pharmaceuticals, LLC - Company Statement
  • High Point Pharmaceuticals, LLC - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • High Point Pharmaceuticals, LLC, Key Information
  • High Point Pharmaceuticals, LLC, Key Facts
  • High Point Pharmaceuticals, LLC - Pipeline by Indication, 2014
  • High Point Pharmaceuticals, LLC - Pipeline by Stage of Development, 2014
  • High Point Pharmaceuticals, LLC - Monotherapy Products in Pipeline, 2014
  • High Point Pharmaceuticals, LLC - Phase II, 2014
  • High Point Pharmaceuticals, LLC - Phase I, 2014
  • High Point Pharmaceuticals, LLC - Preclinical, 2014
  • High Point Pharmaceuticals, LLC - Pipeline by Target, 2014
  • High Point Pharmaceuticals, LLC - Pipeline by Route of Administration, 2014
  • High Point Pharmaceuticals, LLC - Pipeline by Molecule Type, 2014
  • High Point Pharmaceuticals, LLC - Pipeline Products by Mechanism of Action, 2014
  • High Point Pharmaceuticals, LLC - Recent Pipeline Updates, 2014
  • High Point Pharmaceuticals, LLC - Dormant Developmental Projects,2014

List of Figures

  • High Point Pharmaceuticals, LLC - Pipeline by Top 10 Indication, 2014
  • High Point Pharmaceuticals, LLC - Pipeline by Stage of Development, 2014
  • High Point Pharmaceuticals, LLC - Monotherapy Products in Pipeline, 2014
  • High Point Pharmaceuticals, LLC - Pipeline by Top 10 Target, 2014
  • High Point Pharmaceuticals, LLC - Pipeline by Top 10 Route of Administration, 2014
  • High Point Pharmaceuticals, LLC - Pipeline by Top 10 Molecule Type, 2014
  • High Point Pharmaceuticals, LLC - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top